Sentence examples for mutation frequency found from inspiring English sources

The mutation frequency found in borderline malignancies (34%) and carcinomas (13%), is well in line with previous reports [ 3- 5, 22].

Even though the mutation frequency found in this study was higher than those found in low HCC incidence areas, it was still lower than countries with moderate AFB1 exposure like Mexico.

When applied to several colorectal cancer data sets, parameter values consistent with crypt stem cell biology and normal mutation rates were able to match the increase in cancer with aging, and the mutation frequencies found in cancer genomes.

The mutation frequencies found in virus samples from favipiravir-treated animals were greater than in placebo-treated mice with an average of a 2.9-fold increase relative to control animals being observed.

Therefore, we were motivated to compare TP53 mutation type and frequency found in non-hereditary BLBCs, in BRCA1-mutated tumors and in luminal breast tumors.

Concordantly, the highest KRAS/NRAS/BRAF mutation frequency was found in CLL patients with concomitant UM IGHV and trisomy 12-only (38/133, 28.6%).

After irradiation with accelerated uranium ions (8.8 MeV/u, 15,580 keV μm−1) a significant decrease of mutation frequency was found with higher particle fluences (3 × 106 particles cm−2).

In line with this somatic mutation frequency we found only one somatic mutation for each of the three patients.

An elevated TP53 mutation frequency was found among BRCA1 methylated tumours (38.5%) compared with non-methylated tumours (17.2%).

A striking difference in the p53 mutation frequency was found between the carcinoma (30%) and precarcinoma groups (17%) compared with the hyperkeratosis (0%) and common pathological changes (0%) groups (p < 0.05; Table 2).

Furthermore, we compared the frequency of KRAS, BRAF and PIK3CA mutations found in polyps with the frequency found in a series of 103 sporadic colorectal tumours, 50 MSI CRC and 53 MSS CRC, in order to understand the importance of these oncogenic events for the progression of the various types of colorectal cancer.